Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)

the ACCESS and SESSA Research Groups

doi:10.1016/j.atherosclerosis.2018.07.039

Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)

the ACCESS and SESSA Research Groups

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors of the above paper have realized that an error has occurred in the number of eligible individuals selected and individuals who agreed to participate as below (page 142, 7th line of the paragraph immediately under “2.1. Study population”. (current) Of the 2994 eligible individuals selected, 1238 (1094 men) agreed to participate. (correct) Of the 2866 eligible individuals selected, 1236 (1094 men) agreed to participate. They assure that this error does not influence analyses, results, nor conclusions in the paper at all because all the analyses were conducted only for men, and therefore the number of study participants in the analyses is unchanged.

Original language	English
Pages (from-to)	336
Number of pages	1
Journal	Atherosclerosis
Volume	278
DOIs	https://doi.org/10.1016/j.atherosclerosis.2018.07.039
Publication status	Published - Nov 2018
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.atherosclerosis.2018.07.039

Fingerprint

Dive into the research topics of 'Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)'. Together they form a unique fingerprint.

Cite this

the ACCESS and SESSA Research Groups (2018). Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027). Atherosclerosis, 278, 336. https://doi.org/10.1016/j.atherosclerosis.2018.07.039

Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027). / the ACCESS and SESSA Research Groups.
In: Atherosclerosis, Vol. 278, 11.2018, p. 336.

Research output: Contribution to journal › Comment/debate › peer-review

the ACCESS and SESSA Research Groups 2018, 'Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)', Atherosclerosis, vol. 278, pp. 336. https://doi.org/10.1016/j.atherosclerosis.2018.07.039

the ACCESS and SESSA Research Groups. Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027). Atherosclerosis. 2018 Nov;278:336. doi: 10.1016/j.atherosclerosis.2018.07.039

the ACCESS and SESSA Research Groups. / Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027). In: Atherosclerosis. 2018 ; Vol. 278. pp. 336.

@article{ec9ec1f26bba4d6599302d59d394392a,

title = "Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)",

abstract = "The authors of the above paper have realized that an error has occurred in the number of eligible individuals selected and individuals who agreed to participate as below (page 142, 7th line of the paragraph immediately under “2.1. Study population”. (current) Of the 2994 eligible individuals selected, 1238 (1094 men) agreed to participate. (correct) Of the 2866 eligible individuals selected, 1236 (1094 men) agreed to participate. They assure that this error does not influence analyses, results, nor conclusions in the paper at all because all the analyses were conducted only for men, and therefore the number of study participants in the analyses is unchanged.",

author = "{the ACCESS and SESSA Research Groups} and Hirotsugu Ueshima and Takashi Kadowaki and Takashi Hisamatsu and Akira Fujiyoshi and Katsuyuki Miura and Takayoshi Ohkubo and Akira Sekikawa and Aya Kadota and Sayaka Kadowaki and Yasuyuki Nakamura and Naoko Miyagawa and Tomonori Okamura and Yoshikuni Kita and Naoyuki Takashima and Atsunori Kashiwagi and Hiroshi Maegawa and Minoru Horie and Takashi Yamamoto and Takeshi Kimura and Toru Kita",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier B.V.",

year = "2018",

month = nov,

doi = "10.1016/j.atherosclerosis.2018.07.039",

language = "English",

volume = "278",

pages = "336",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Corrigendum to “Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.” [Atherosclerosis 246 (March 2016) 141–147](S0021915015302562)(10.1016/j.atherosclerosis.2015.12.027)

AU - the ACCESS and SESSA Research Groups

AU - Ueshima, Hirotsugu

AU - Kadowaki, Takashi

AU - Hisamatsu, Takashi

AU - Fujiyoshi, Akira

AU - Miura, Katsuyuki

AU - Ohkubo, Takayoshi

AU - Sekikawa, Akira

AU - Kadota, Aya

AU - Kadowaki, Sayaka

AU - Nakamura, Yasuyuki

AU - Miyagawa, Naoko

AU - Okamura, Tomonori

AU - Kita, Yoshikuni

AU - Takashima, Naoyuki

AU - Kashiwagi, Atsunori

AU - Maegawa, Hiroshi

AU - Horie, Minoru

AU - Yamamoto, Takashi

AU - Kimura, Takeshi

AU - Kita, Toru

PY - 2018/11

Y1 - 2018/11

N2 - The authors of the above paper have realized that an error has occurred in the number of eligible individuals selected and individuals who agreed to participate as below (page 142, 7th line of the paragraph immediately under “2.1. Study population”. (current) Of the 2994 eligible individuals selected, 1238 (1094 men) agreed to participate. (correct) Of the 2866 eligible individuals selected, 1236 (1094 men) agreed to participate. They assure that this error does not influence analyses, results, nor conclusions in the paper at all because all the analyses were conducted only for men, and therefore the number of study participants in the analyses is unchanged.

AB - The authors of the above paper have realized that an error has occurred in the number of eligible individuals selected and individuals who agreed to participate as below (page 142, 7th line of the paragraph immediately under “2.1. Study population”. (current) Of the 2994 eligible individuals selected, 1238 (1094 men) agreed to participate. (correct) Of the 2866 eligible individuals selected, 1236 (1094 men) agreed to participate. They assure that this error does not influence analyses, results, nor conclusions in the paper at all because all the analyses were conducted only for men, and therefore the number of study participants in the analyses is unchanged.

UR - http://www.scopus.com/inward/record.url?scp=85052325597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052325597&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2018.07.039

DO - 10.1016/j.atherosclerosis.2018.07.039

M3 - Comment/debate

C2 - 30166205

AN - SCOPUS:85052325597

SN - 0021-9150

VL - 278

SP - 336

JO - Atherosclerosis

JF - Atherosclerosis

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this